These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18815313)

  • 1. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.
    Van de Walle GR; Peters ST; VanderVen BC; O'Callaghan DJ; Osterrieder N
    J Virol; 2008 Dec; 82(23):11859-68. PubMed ID: 18815313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.
    Frampton AR; Stolz DB; Uchida H; Goins WF; Cohen JB; Glorioso JC
    J Virol; 2007 Oct; 81(20):10879-89. PubMed ID: 17670830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.
    Spiesschaert B; Osterrieder N; Azab W
    Viruses; 2015 Feb; 7(2):522-42. PubMed ID: 25654240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.
    Azab W; Osterrieder N
    J Virol; 2012 Feb; 86(4):2031-44. PubMed ID: 22171258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein H and α4β1 integrins determine the entry pathway of alphaherpesviruses.
    Azab W; Lehmann MJ; Osterrieder N
    J Virol; 2013 May; 87(10):5937-48. PubMed ID: 23514881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
    Frampton AR; Goins WF; Cohen JB; von Einem J; Osterrieder N; O'Callaghan DJ; Glorioso JC
    J Virol; 2005 Mar; 79(5):3169-73. PubMed ID: 15709036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.
    Azab W; Zajic L; Osterrieder N
    Vet Res; 2012 Aug; 43(1):61. PubMed ID: 22909178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of alphaherpesvirus glycoprotein H to surface α4β1-integrins activates calcium-signaling pathways and induces phosphatidylserine exposure on the plasma membrane.
    Azab W; Gramatica A; Herrmann A; Osterrieder N
    mBio; 2015 Oct; 6(5):e01552-15. PubMed ID: 26489864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.
    Delboy MG; Patterson JL; Hollander AM; Nicola AV
    Virol J; 2006 Dec; 3():105. PubMed ID: 17192179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
    Osterrieder N; Van de Walle GR
    Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious entry of equine herpesvirus-1 into host cells through different endocytic pathways.
    Hasebe R; Sasaki M; Sawa H; Wada R; Umemura T; Kimura T
    Virology; 2009 Oct; 393(2):198-209. PubMed ID: 19720389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread.
    Neubauer A; Braun B; Brandmuller C; Kaaden OR; Osterrieder N
    Virology; 1997 Jan; 227(2):281-94. PubMed ID: 9018127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells.
    Frampton AR; Uchida H; von Einem J; Goins WF; Grandi P; Cohen JB; Osterrieder N; Glorioso JC
    Vet Microbiol; 2010 Feb; 141(1-2):12-21. PubMed ID: 19713056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines.
    Wellington JE; Lawrence GL; Love DN; Whalley JM
    Arch Virol; 1996; 141(9):1785-93. PubMed ID: 8893800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.
    Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W
    J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.
    Laval K; Favoreel HW; Poelaert KC; Van Cleemput J; Nauwynck HJ
    J Virol; 2015 Nov; 89(21):10912-23. PubMed ID: 26292328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry.
    Sasaki M; Kim E; Igarashi M; Ito K; Hasebe R; Fukushi H; Sawa H; Kimura T
    J Biol Chem; 2011 Nov; 286(45):39370-8. PubMed ID: 21949188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host cell tropism of equine herpesviruses: glycoprotein D of EHV-1 enables EHV-4 to infect a non-permissive cell line.
    Whalley JM; Ruitenberg KM; Sullivan K; Seshadri L; Hansen K; Birch D; Gilkerson JR; Wellington JE
    Arch Virol; 2007; 152(4):717-25. PubMed ID: 17171298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haemagglutination activity of equine herpesvirus type 1 glycoprotein C.
    Andoh K; Hattori S; Mahmoud HY; Takasugi M; Shimoda H; Bannai H; Tsujimura K; Matsumura T; Kondo T; Kirisawa R; Mochizuki M; Maeda K
    Virus Res; 2015 Jan; 195():172-6. PubMed ID: 25456403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equid herpesvirus type 4 uses a restricted set of equine major histocompatibility complex class I proteins as entry receptors.
    Azab W; Harman R; Miller D; Tallmadge R; Frampton AR; Antczak DF; Osterrieder N
    J Gen Virol; 2014 Jul; 95(Pt 7):1554-1563. PubMed ID: 24722677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.